相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Phase I/II study of the oral HIF-2 α inhibitor MK-6482 in patients with advanced clear cell renal cell carcinoma (RCC).
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
David A. Braun et al.
NATURE MEDICINE (2020)
PAK4 inhibition improves PD-1 blockade immunotherapy
Gabriel Abril-Rodriguez et al.
NATURE CANCER (2020)
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
Silvia Pastorekova et al.
CANCER AND METASTASIS REVIEWS (2019)
Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors
Annelies Verbiest et al.
CLINICAL GENITOURINARY CANCER (2019)
WNT Signaling in Cancer Immunosurveillance
Lorenzo Galluzzi et al.
TRENDS IN CELL BIOLOGY (2019)
Biomarker analyses from JAVELIN Renal 101: Avelumab plus axitinib (A plus Ax) versus sunitinib (S) in advanced renal cell carcinoma (aRCC).
Toni K. Choueiri et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
Nicolas Jacquelot et al.
CELL RESEARCH (2019)
RIG-I activation is critical for responsiveness to checkpoint blockade
Simon Heidegger et al.
SCIENCE IMMUNOLOGY (2019)
Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial
A. Ari Hakimi et al.
CANCER DISCOVERY (2019)
PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function
Sarah Whelan et al.
CANCER IMMUNOLOGY RESEARCH (2019)
The AIM2 inflammasome: Sensor of pathogens and cellular perturbations
Jerome Lugrin et al.
IMMUNOLOGICAL REVIEWS (2018)
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma
Michael B. Atkins et al.
CANCER TREATMENT REVIEWS (2018)
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
David F. McDermott et al.
NATURE MEDICINE (2018)
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao et al.
SCIENCE (2018)
Long Non-coding RNAs: Regulators of Viral Infection and the Interferon Antiviral Response
Lipeng Qiu et al.
FRONTIERS IN MICROBIOLOGY (2018)
1137PDIdentification of adenosine pathway genes associated with response to therapy with the adenosine receptor antagonist CPI-444
S Willingham et al.
ANNALS OF ONCOLOGY (2018)
CCL28 chemokine: An anchoring point bridging innate and adaptive immunity
Teena Mohan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma The ARISER Randomized Clinical Trial
Karim Chamie et al.
JAMA ONCOLOGY (2017)
De novo non-synonymous TBL1XR1 mutation alters Wnt signaling activity
Akira Nishi et al.
SCIENTIFIC REPORTS (2017)
Discovery of COM701, a therapeutic antibody targeting the novel immune checkpoint PVRIG, for the treatment of cancer.
Spencer Liang et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
Toni K. Choueiri et al.
CLINICAL CANCER RESEARCH (2016)
Atezolizumab, an Anti-Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study
David F. McDermott et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Characterization of clear cell renal cell carcinoma by gene expression profiling
Bryan J. Thibodeau et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2016)
The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti-PD-1 Response in Patients with Renal Cell Carcinoma
Maria Libera Ascierto et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Swainsonine exposure induces impairment of host immune response in pregnant BALB/c mice
Yanchun Hu et al.
BMC IMMUNOLOGY (2015)
Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting
Benoit Beuselinck et al.
CLINICAL CANCER RESEARCH (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab
Mario Sznol et al.
Journal for ImmunoTherapy of Cancer (2015)
A Role for Matrix Metalloproteinases in Regulating Mammary Stem Cell Function via the Wnt Signaling Pathway
Kai Kessenbrock et al.
CELL STEM CELL (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
Mark J. Selby et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Regulation of mouse NK cell development and function by cytokines
Antoine Marcais et al.
FRONTIERS IN IMMUNOLOGY (2013)
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition -: The role of HIF-1α, HIF-2α, and other pathways
Gareth P. Elvidge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data
AR Abbas et al.
GENES AND IMMUNITY (2005)